National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

Found 19,249 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1283 out of 1,925

Result pages: prev   1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292   next


VAERS ID: 1339535 (history)  
Form: Version 2.0  
Age: 92.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-05-11
Onset:2021-05-12
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Pneumonia aspiration, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-15
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:pyrexia; Test Date: 20210511; Test Name: Body temperature; Result Unstructured Data: Test Result:reported as uncertain
CDC Split Type: JPPFIZER INC2021564216

Write-up: Pneumonia aspiration; Pyrexia; This is a spontaneous report from a contactable physician. This is a report received from the Regulatory Authority. Regulatory authority report number is v21107080. A 92-year-old male patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 11May2021 (Batch/Lot number was not reported) at 92-years-old as a single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On an unspecified date, the patient experienced: pyrexia (non-serious). On 12May2021, the patient experienced: pneumonia aspiration (death, hospitalization, medically significant). The patient was hospitalized for pneumonia aspiration from 12May2021 to an unknown date. The clinical course was reported as follows: The patient was a 92-year and 10-month-old male. Body temperature before vaccination was not provided (reported as uncertain). No information on medical history, concomitant medications, or family history was provided (reported as uncertain). On 11May2021, the patient received BNT162b2 (COMIRNATY, Solution for injection, Dose number, Lot number and Expiration date was not reported). On an unspecified date, the patient experienced pyrexia. On 12May2021 (1 day after the vaccination), the patient experienced pneumonia aspiration, and was hospitalized. On 15May2021 (4 days after the vaccination), the patient died of pneumonia aspiration (dysphagia), although treatment was provided. It was not reported if an autopsy was performed. The reporting physician classified the event as serious (fatal outcome) and assessed that there was no causal relationship with BNT162b2. Dysphagia was reported as another possible cause of the event. The reporting physician commented as follows: It was considered that there was no causal relationship with BNT162b2. The patient underwent lab tests and procedures which included body temperature: reported as uncertain on 11May2021, body temperature: pyrexia on an unspecified date. Therapeutic measures were taken as a result of pneumonia aspiration. The clinical outcome of the event, pyrexia, was unknown. The clinical outcome of the event, pneumonia aspiration, was fatal. The patient died on 15May2021 due to pneumonia aspiration and dysphagia. It was unknown if an autopsy was performed. The batch/lot numbers for the vaccine, bnt162b2, were not provided and will be requested during follow up. ; Reported Cause(s) of Death: pneumonia aspiration; dysphagia


VAERS ID: 1339536 (history)  
Form: Version 2.0  
Age: 34.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-21
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER9480 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Pulmonary artery thrombosis
SMQs:, Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-01
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: NONE
Allergies:
Diagnostic Lab Data:
CDC Split Type: JPPFIZER INC2021564364

Write-up: Pulmonary artery thromboembolism due to deep vein thrombosis leg; Pulmonary artery thromboembolism due to deep vein thrombosis leg; This is a spontaneous report from a contactable physician received via regulatory authority. A 34-year-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscularly on 21Apr2021 at 12:00 (Batch/Lot Number: ER9480; Expiration Date: 31Jul2021) at 34-years-old as a single dose for COVID-19 immunization. The patient''s medical history was reported as none. Concomitant medications were not reported. On an unspecified date, the patient experienced: pulmonary artery thromboembolism due to deep vein thrombosis leg (death, medically significant). The clinical course was reported as follows: The patient was a 34-year-old male. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient received other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient had no other medical history. On 21Apr2021 at 12:00 (the day of vaccination), the patient received?the first single dose of BNT162b2 (COMIRNATY, Solution for injection, Lot number ER9480, Expiration date 31Jul2021) intramuscularly for COVID-19 immunization. On an unspecified date, the patient experienced pulmonary artery thromboembolism due to deep vein thrombosis leg. The event resulted in death. The outcome of the events was fatal. No treatment was given. The reported narrative was as follows: On 10May2021 (19 days after the vaccination), the patient was found dead in a car. The estimated date of death according to the police was 05May2021. Forensic autopsy results revealed pulmonary artery thromboembolism due to deep vein thrombosis leg. Date of death was reported as May2021. Cause of death was pulmonary artery thromboembolism. Autopsy remarks included pulmonary artery thromboembolism. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was fatal. The patient died on an unspecified date in May2021 due to pulmonary artery thromboembolism. An autopsy was performed that revealed pulmonary artery thromboembolism due to deep vein thrombosis leg.; Sender''s Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of pulmonary artery thromboembolism and deep vein thrombosis leg, due to temporal relationship. However, the reported events may possibly represent intercurrent medical conditions in this patient. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including complete autopsy results, serum toxicology screen and coagulation panel, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: Pulmonary artery thromboembolism; Autopsy-determined Cause(s) of Death: Pulmonary artery thromboembolism due to deep vein thrombosis leg; Pulmonary artery thromboembolism due to deep vein thrombosis leg


VAERS ID: 1339538 (history)  
Form: Version 2.0  
Age: 73.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-05-16
Onset:2021-05-17
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Cardio-respiratory arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-17
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abdominal aortic aneurysm; Myocardial infarction old; Rectal cancer; Surgery
Allergies:
Diagnostic Lab Data:
CDC Split Type: JPPFIZER INC2021570910

Write-up: Cardio-respiratory arrest; This is a spontaneous report from a contactable physician received from the Regulatory Authority. The regulatory authority report number is v21107238. A 73-year and 7-month-old male patient received BNT162B2 (COMIRNATY), via an unspecified route of administration on 16May2021 at 14:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included abdominal aortic aneurysm, non-ongoing myocardial infarction old on an unspecified date, and status post surgery for rectal cancer (non-ongoing surgery on an unspecified date). The patient''s concomitant medications were not reported. The patient experienced cardio-respiratory arrest on 17May2021 at 07:50 (17 hours and 50 minutes after the vaccination), which was reported as fatal. The clinical course was reported as follows: The body temperature before vaccination was not provided. On 16May2021 (the day of vaccination), and on 17May2021, at 05:00 (15 hours after the vaccination), no particular abnormalities were observed. At 07:50 on 17May2021 (17 hours and 50 minutes after vaccination), when a staff member visited the patient''s room the next time, she had been already in cardio-respiratory arrest. The patient died on 17May2021. The cause of death was reported as cardio-respiratory arrest. It was not reported if an autopsy was performed. The reporting physician assessed that the causality between the event and BNT162B2 as unassessable (reported as unknown). Other possible causes of the event, such as any other diseases, was reported as unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Reported Cause(s) of Death: Cardio-respiratory arrest


VAERS ID: 1339539 (history)  
Form: Version 2.0  
Age: 89.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-05-19
Onset:2021-05-19
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, Body temperature, Cardiac arrest, Cardio-respiratory arrest, Physical examination, Respiration abnormal
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-19
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: FRANDOL; BISONO
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Activities of daily living impaired; Cardiac failure chronic (hospitalized until Apr2021); Home care; Hospitalization; Oral intake reduced; Total parenteral nutrition (due to poor oral intake since hospitalization)
Allergies:
Diagnostic Lab Data: Test Date: 20210519; Test Name: Blood pressure; Result Unstructured Data: Test Result:157/80 mmHg; Test Date: 20210519; Test Name: Body temperature; Result Unstructured Data: Test Result:36.9 Centigrade; Comments: Before vaccination; Test Date: 20210519; Test Name: examination; Result Unstructured Data: Test Result:in a state of cardio-respiratory arrest
CDC Split Type: JPPFIZER INC2021572376

Write-up: something was wrong with her respiratory state/her respiratory condition suddenly changed; Cardio-respiratory arrest; Asystole; This is a spontaneous report from a contactable physician. This is a report received from the Regulatory Authority (RA). Regulatory authority report number is v21107471. An 89-year-old female patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 19May2021 10:15 (Batch/Lot number was not reported) at 89-years-old as a single dose for COVID-19 immunization. Medical history included cardiac failure chronic from an unknown date and unknown if ongoing (hospitalized until Apr2021), hospitalized from an unknown date to 13Apr2021, home care from 13Apr2021 to an unknown date, total parenteral nutrition from an unknown date and unknown if ongoing (due to poor oral intake since hospitalization), inadequate oral intake from an unknown date and unknown if ongoing, ADL (activities of daily living) was full assist from an unknown date and unknown if ongoing. Concomitant medications included isosorbide dinitrate (FRANDOL, Transdermal patch/ tape) taken for an unspecified indication, start and stop date were not reported; bisoprolol (BISONO, Transdermal patch/ tape) taken for an unspecified indication, start and stop date were not reported. On 19May2021 at 11:15, the patient experienced: something was wrong with her respiratory state/her respiratory condition suddenly changed (death). On 19May2021, the patient experienced: cardio-respiratory arrest (death, medically significant), and asystole (death, medically significant). The events required an emergency room visit. The clinical course was reported as follows: The patient was an 89-year and 1-month-old female. Body temperature before vaccination was 36.9 degrees Centigrade. The patient had a medical history of cardiac failure chronic, and she had been hospitalized until Apr2021. On 13Apr2021, she discharged home and started to receive home care. She was continuously receiving total parenteral nutrition because of inadequate oral intake. The patient was using isosorbide dinitrate (FRANDOL tape) and bisoprolol (BISONO tape). The patient had no significant family history. On 19May2021 at 10:15 (the day of vaccination), the patient received the first dose of BNT162b2 (COMIRNATY, Solution for injection, Lot number not provided) via an unspecified route of administration as a single dose for COVID-19 immunization. On 19May2021 at 11:15 (1 hour after the vaccination), the patient experienced that something was wrong with her respiratory state. On 19May2021 (specific time not reported), she died. It was not reported if an autopsy was performed. The course of the event was as follows: The patient stayed in bed all day. The level of ADL (activities of daily living) was full assist. Oral intake was almost impossible. She had been receiving total parenteral nutrition since hospitalization. On 19May2021, the reporting physician made a home visit. At 10:15 on the same day, the vaccination was administered. The reporting physician observed the patient until around 11:00 and returned to the hospital. On 19May2021 at 11:19, the reporting physician was informed by her family member that something was wrong with her respiratory state, and so he examined the patient emergently. On 19May2021 at 11:25, at the time of examination, she was in a state of cardio-respiratory arrest. Then, he performed tracheal intubation, cardiopulmonary resuscitation and intravenous administration of adrenaline together with the emergency team who arrived at around the same time as him. On 19May2021 at 11:52, the patient was transferred to a nearby emergency medical facility. While transporting to a medical facility, she was in a state of asystole and resuscitation was continuously done. However, she died without return of spontaneous circulation. The reporting physician classified the event as serious (Fatal outcome) and assessed the causality between the event and BNT162b2 as unassessable. Other possible cause of the event was reported as follows: The patient was observed for around 45 minutes after the vaccination, but no change was noted in her vital signs. One hour after the vaccination, her respiratory condition suddenly changed. The reporting physician commented as follows: After the vaccination the physician stayed at home and observed her for about 45 minutes. The blood pressure measured at that time was 157/80 mmHg. When he left her house (around 11:00), she waved her hand and greeted him. From the time between leaving home and receiving the phone call (11:19), her respiratory condition suddenly changed. When the physician examined her emergently and resuscitated her with the emergency team, she was in a state of asystole, and she did not respond to adrenaline. The patient underwent lab tests and procedures which included blood pressure: 157/80 mmHg on 19May2021, body temperature: 36.9 Centigrade on 19May2021 (Before vaccination), examination: in a state of cardio-respiratory arrest on 19May2021. Therapeutic measures were taken as a result of the events. The clinical outcome of the events was fatal. The patient died on 19May2021 due to respiration abnormal, cardio-respiratory arrest, and asystole. It was unknown if an autopsy was performed. The batch/lot numbers for the vaccine, bnt162b2, were not provided and will be requested during follow up. ; Reported Cause(s) of Death: Respiration abnormal; Cardio-respiratory arrest; Asystole


VAERS ID: 1339906 (history)  
Form: Version 2.0  
Age: 86.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-09
Onset:2021-03-14
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2166 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Echocardiogram, Electrocardiogram, Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-15
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Targeted heart / VCI emergency ultrasound; Result Unstructured Data: Test Result:strong suspicion of obstructive shock due to massi; Comments: emergency ultrasound heart / VCI: wide right system, D-shape septum, McCullen sign +, empty left ventricle with moderate LVF, VCI wide, does not collapse. No pericardial fluid. Conclusion: clear signs of legal burden with positive mc cullen sign, strong suspicion of obstructive shock due to massive pulmonary embolism.; Test Name: ECG; Result Unstructured Data: Test Result:80; Comments: SR 80/min
CDC Split Type: NLPFIZER INC2021544894

Write-up: massive pulmonary embolism; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority NL-LRB-00535901. An 86-year-old female patient received second dose bnt162b2 (COMIRNATY), via an unspecified route of administration on 09Mar2021 (Batch/Lot Number: EP2166) at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received first dose bnt162b2 (COMIRNATY), via an unspecified route of administration on 02Feb2021 at single dose for COVID-19 immunisation and experienced no adverse event. The patient experienced massive pulmonary embolism on 14Mar2021. Targeted heart / vci emergency ultrasound (ER): wide right system, D-shape septum, Mc cullen sign +, empty left ventricle with moderate Left ventricular failure (LVF), VCI wide, does not collapse. No pericardial fluid. Conclusion: clear signs of legal tax with positive mc cullen sign, strong suspicion of obstructive shock due to massive pulmonary embolism. Electrocardiogram (ECG): SR 80 / min, normal cardiac axis, normal conductances, minimum segment (ST) depressions in I, V5-V6, no segment (ST) elevations, normal T-waves. After one-time filling (started from ambulance) no improvement, hemodynamics. With clear signs of legal tax on targeted emergency ultrasound with high suspicion of obstructive shock pulmonary embolism now no longer filled (due to worsening of circulatory situation in case of obstruction of the right system). Considering that it is too unstable for Computed tomography (CT) hemodynamically, consult IC about yes / no thrombolysis given deep shock and clear desire not to resuscitate want to become. Decided after assessment by intensivis. The patient did not have previous COVID-19 infection. The patient died on 15Mar2021 due to lung embolism. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected. ; Reported Cause(s) of Death: massive pulmonary embolism


VAERS ID: 1339907 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-05-07
Onset:2021-05-09
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Atrial fibrillation, Cerebrovascular accident, SARS-CoV-2 test
SMQs:, Supraventricular tachyarrhythmias (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-09
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FUROSEMIDE; RIVAROXABAN; OMEPRAZOL; ALLOPURINOL; NORTRIPTYLINE; SIMVASTATINE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19; Encephalitis herpes
Allergies:
Diagnostic Lab Data: Test Date: 20210412; Test Name: corona, confirmed with test; Test Result: Positive
CDC Split Type: NLPFIZER INC2021544984

Write-up: deceased, suspected CVA; deceased, suspected CVA in AF; This is as spontaneous report received from a contactable physician downloaded from the regulatory authority-WEB. The regulatory authority report number NL-LRB-00536469. A 84-years-old male patient received the second dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 07May2021 (Batch/Lot Number: Unknown) as 0.3 ml single for covid-19 immunisation. Patient received the first dose on 02Apr2021. Medical history included covid-19 from 12Apr2021 to an unknown date, meningoencephalitis herpetic from an unknown date and unknown if ongoing. Concomitant medications included furosemide taken for an unspecified indication, start and stop date were not reported; rivaroxaban taken for an unspecified indication, start and stop date were not reported; omeprazole (OMEPRAZOL) taken for an unspecified indication, start and stop date were not reported; allopurinol taken for an unspecified indication, start and stop date were not reported; nortriptyline taken for an unspecified indication, start and stop date were not reported; simvastatine taken for an unspecified indication, start and stop date were not reported. The patient experienced died suddenly 2 days after vaccination with cerebrovascular accident, fibrillation atrial, in between no manifestations of muscle pain, fever. The patient died on 09May2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected. Information on lot and batch numbers cannot be obtained.; Reporter''s Comments: Past drug therapy BioNTech/Pfizer vaccin (Comirnaty): yes ADRs: no Date:02Apr2021 Additional information ADR: died suddenly 2 days after vaccination, in between no manifestations of muscle pain, fever. citizen service number available: yes Previous COVID-19 infection: disease symptoms: none diagnostic procedures: no; Reported Cause(s) of Death: AF; suspected stroke in AF in patient with status after herpes encephalitis and recently Covid-19


VAERS ID: 1339908 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-25
Onset:2021-04-29
   Days after vaccination:63
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Cardiac failure
SMQs:, Cardiac failure (narrow), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-29
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC2021544908

Write-up: Death, heart failure; This is a spontaneous report from a contactable consumerl downloaded from the regulatory authority, regulatory authority number NL-LRB-00536831. An 82-year-old female patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 25Feb2021 as 2nd dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (COMIRNATY) on 18Jan2021 for COVID-19 Immunization. In the evening of 28Apr2021, the patient went to bed fine, but did not wake up the next morning. Remained in a comatose state until she passed away around 3:00 PM (29Apr2021). Cause: heart failure, but her heart had nothing to do with her, super strong. Unclear reason ... people talked about ''acute'' heart failure. There is no previous COVID-19 infection. The patient died on 29Apr2021. It was not reported if an autopsy was performed. No follow-up attempts are possible, information on batch/lot number cannot be obtained.; Reported Cause(s) of Death: Death, heart failure


VAERS ID: 1339909 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-06
Onset:2021-04-28
   Days after vaccination:22
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW9127 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Cerebral haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-29
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CLOPIDOGREL
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC2021553991

Write-up: Cerebral haemorrhage 7 days after successful surgery resulting in death of date 29Apr2021 No complaints after vaccination.; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority NL-LRB-00536980, received from Regulatory Authority. A 74-year-old male patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 13Apr2021 (Batch/Lot Number: EW9127) as single dose for covid-19 immunisation; clopidogrel (manufacturer unknown, 75 mg), via an unspecified route of administration from 06Apr2021 (Batch/Lot Number: Unknown) to an unspecified date, at unspecified dose daily in connection with carotid artery narrowing/surgery in 21Apr2021. The patient''s medical history was not reported. Concomitant medications included non specified blood pressure medication, and non specified cholesterol lowering agent (In connection with surgery under anesthesia, blood pressure reducer/blood thinner/cholestorol reducer were prescribed). The patient experienced cerebral haemorrhage on 28Apr2021, 7 days after successful surgery resulting in death of date 29Apr2021, no complaints after vaccination. The outcome of cerebral haemorrhage was fatal. The action taken in response to the event for clopidogrel was not applicable. It was unknown if an autopsy was performed. Patient had no previous COVID-19 infection. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Cerebral haemorrhage


VAERS ID: 1339910 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-05-08
Onset:2021-05-10
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: SARS-CoV-2 test, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-10
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: COPD (COPD gold II); Type 2 diabetes mellitus
Preexisting Conditions: Medical History/Concurrent Conditions: Cerebrovascular accident; COVID-19 (Previous COVID-19 infection: disease symptoms: little.)
Allergies:
Diagnostic Lab Data: Test Date: 20201209; Test Name: corona, confirmed with test; Test Result: Positive
CDC Split Type: NLPFIZER INC2021554011

Write-up: Died unexpectedly 1.5 days after 2nd COVID vaccination.; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number NL-LRB-00537147. An 84-year-old male patient received the second dose of BNT162B2 (COMIRNATY), via an unspecified route of administration on 08May2021 (Batch/Lot number was not reported) as a single dose for covid-19 immunization. Medical history included COVID-19 from 09Dec2020, cerebrovascular accident from 2003; ongoing type 2 diabetes mellitus, ongoing COPD gold II. Previous COVID-19 infection: disease symptoms: little. The patient''s concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) for covid-19 immunization with no adverse reaction. The patient died unexpectedly (Sudden death) 36 hours (1.5 days) after 2nd COVID vaccination on 10May2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 09Dec2020. The patient died on 10May2021. It was unknown if an autopsy was performed. The outcome of the event was fatal. No follow-up attempts are possible, information on batch number cannot be obtained.; Reported Cause(s) of Death: Sudden death


VAERS ID: 1339911 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-25
Onset:2021-04-30
   Days after vaccination:64
Submitted: 0000-00-00
Entered: 2021-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6790 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-10
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Pneumonia recurrent
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210430; Test Name: Diagnostic procedures were regarded the specific variant of Covid-19; Result Unstructured Data: Test Result: Specific variant of Covid-19
CDC Split Type: NLPFIZER INC2021553987

Write-up: patient was the second resident in nursing home who died of covid19, despite being vaccinated/ Diagnostic procedures were regarded the specific variant of Covid-19; patient was the second resident in nursing home who died of covid19, despite being vaccinated/ Diagnostic procedures were regarded the specific variant of Covid-19; This is a spontaneous report from a contactable physician downloaded from the regulatory authority, regulatory authority number NL-LRB-00537347. A 76-year-old female patient received BNT162B2 (COMIRNATY, Solution for injection), first dose via an unspecified route of administration on 28Jan2021 (batch/lot number unknown) as 0.3ml single dose, second dose via an unspecified route of administration on 25Feb2021 (lot number: EJ6790) as 0.3ml single dose for covid-19 immunization. Medical history included ongoing recurring pneumonia, no previous COVID-19 infection. The patient''s concomitant medications were not reported. The patient died on 10May2021 due to Covid-19 and vaccination failure since 30Apr2021 following administration of covid-19 vaccine Pfizer injection 2 months after start (as reported). Confounding factor was recurring pneumonia. Diagnostic procedures were regarded the British variant of Covid-19 on 30Apr2021. The events were treated with dexamethasone and oxygen therapy. The patient was the second resident in nursing home who died of covid19, despite being vaccinated. The outcome of the events was fatal. It was unknown if an autopsy was performed, cause of death was reported as Covid-19 in known lung disease. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: patient was the second resident in nursing home who died of covid19, despite being vaccinated/ Diagnostic procedures were regarded the British variant of Covid-19; patient was the second resident in nursing home who died of covid19, despite being vac


Result pages: prev   1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1283&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166